HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Transcatheter arterial chemoembolization combined with external radiation for primary liver cancer].

AbstractOBJECTIVE:
To evaluate the therapeutic efficacy of transcatheter arterial chemoembolization (TACE) combined with external radiotherapy (RT) for primary liver cancer.
METHODS:
The effectiveness of combined therapy with TACE and RT (76 cases) and TACE therapy alone (68 cases) was prospectively nonrandomly studied.
RESULTS:
In TACE + RT group, the response rate (CR + PR) was 53.9%, and the 1-, 2-, 3-year survival rate was 71.6%, 49.0%, and 44.5%, respectively. In contrast, the response rate of TACE alone was 33.8%, and the 1-, 2-, 3-year survival rate was 51.8%, 17.3%, and 17.3%, respectively. The difference between these two groups was statistically significant (P < 0.05). Factors of prognostic significance in the TACE + RT group were tumor type, tumor cell thrombi in the portal system, number of TACE treatment and the use of gelform in embolization.
CONCLUSION:
TACE + RT is more effective than TACE therapy alone. Understanding of the prognostic factors is useful for selection and management of patients.
AuthorsW Guo, M Song, E Yu
JournalZhonghua zhong liu za zhi [Chinese journal of oncology] (Zhonghua Zhong Liu Za Zhi) Vol. 21 Issue 1 Pg. 25-8 (Jan 1999) ISSN: 0253-3766 [Print] China
PMID11776790 (Publication Type: English Abstract, Journal Article)
Chemical References
  • alpha-Fetoproteins
Topics
  • Adult
  • Aged
  • Chemoembolization, Therapeutic
  • Combined Modality Therapy
  • Female
  • Humans
  • Liver Neoplasms (mortality, radiotherapy, therapy)
  • Male
  • Middle Aged
  • Survival Rate
  • alpha-Fetoproteins (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: